SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-015387
Filing Date
2023-08-31
Accepted
2023-08-31 16:19:40
Documents
15
Period of Report
2023-08-30
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ampe-20230830x8k.htm   iXBRL 8-K 38683
2 EX-3.1 ampe-20230830xex3d1.htm EX-3.1 9309
3 EX-99.1 ampe-20230830xex99d1.htm EX-99.1 10158
4 GRAPHIC ampe-20230830xex99d1001.jpg GRAPHIC 10740
  Complete submission text file 0001558370-23-015387.txt   201972

Data Files

Seq Description Document Type Size
5 EX-101.SCH ampe-20230830.xsd EX-101.SCH 3369
6 EX-101.LAB ampe-20230830_lab.xml EX-101.LAB 16014
7 EX-101.PRE ampe-20230830_pre.xml EX-101.PRE 10865
9 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20230830x8k_htm.xml XML 4867
Mailing Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112
Business Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 231229285
SIC: 2834 Pharmaceutical Preparations